Zakira Kerimbayeva

Zakira Kerimbayeva

Auto-generated profile, based on publicly available information

Zakira Kerimbayeva

Astana Med Univ, NCJSC, Nur Sultan, Kazakhstan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
BTBekzat M. Turmakhanbetov
Bekzat M. Turmakhanbetov
GTGulnara Zh Tokmurzieva
Gulnara Zh Tokmurzieva
ZKZakira A. Kerimbaeva
Zakira A. Kerimbaeva
RDReeti Debnath
Reeti Debnath
MNMaral G. Nogaeva
Maral G. Nogaeva
ATAigul Tazhiyeva
Aigul Tazhiyeva

25 February 2024 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
AAAinur Assan
Ainur Assan
GZGulnur Zhakhina
Gulnur Zhakhina
ZKZakira Kerimbayeva
Zakira Kerimbayeva
IMIkilas Moldaliyev
Ikilas Moldaliyev
DSDmitry Sychev
Dmitry Sychev
AGAbduzhappar Gaipov
Abduzhappar Gaipov
Brief Description: The investigation of glomerular disease prevalence is vital for comprehending chronic kidney disease development, particularly in regions like Kazakhstan and Central Asia, where confirming data is lacking. This study focuses on the epidemiology of glomerular diseases, utilizing registered cases of glomerular diseases in the national electronic health system. Research Methods: The research involves data from 31,421 patients recorded in the Unified National Electronic Healthcare System database, covering glomerular diseases with ICD-10 codes N01-N08 between 2014 and 2019. Descriptive statistics encompass demographic characteristics, all-cause mortality, prevalence and incidence rates, and comorbidities. Results: Results reveal a substantial rise in diagnosed cases from 7,756 (2014) to 30,686 (2019), with corresponding all-cause mortality increasing from 254 to 1,025. Also, new cases went up from 4,875 (2014) to 6,320 (2019). Over the period, 51% were women, 49% were men, and 67% were of Kazakh ethnicity. Russian nationality constituted 16%, and other ethnic groups comprised 17%. Diabetes mellitus emerged as the primary comorbidity, associated with 20% of cases. Conclusion: This is the first descriptive study in Central Asia scrutinizing the epidemiology of patients with glomerular diseases (ICD-10 code N01-N08) using administrative healthcare data in Kazakhstan. The findings indicate an escalation in prevalence and mortality, coupled with a gradual increase in incidence among glomerular disease patients from 2014 to 2019. The study underscores the pivotal role of diabetes mellitus as a predominant comorbidity in this context.

26 October 2022 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
AAAinur Assan
Ainur Assan
IMIkilas Moldaliyev
Ikilas Moldaliyev
ZKZakira Kerimbayeva
Zakira Kerimbayeva
AGAbduzhappar Gaipov
Abduzhappar Gaipov
DUDinara Utepova
Dinara Utepova
MAMohamad Aljofan
Mohamad Aljofan
Introduction: The rapid development of the pharmaceutical industry has increased the need to assess and monitor the use of medicines. Thus, necessitates the importance of monitoring the appropriate use of medicines including antimicrobials. Objective: Pharmacoeconomic analysis of pharmacotherapy in the nephrology department at a multidisciplinary hospital. Methods: The study is a retrospective analysis of medicine use and expenditure. The study utilized the ABC-VEN analysis of medical use and the WHO-AWaRe-2021 analysis of antibiotic use, to determine the prescription and financial trends of the nephrology department (30 beds) of a multidisciplinary regional hospital (total 844 beds) in Turkestan, Kazakhstan 2018-2021. Results: The analyzed costs of drugs included 116 international nonproprietary names prescribed to patients from the nephrology department during the study period. In total, pharmacotherapy costs increased by 52.6% in 2021 compared to 2018. Five INN drugs were purchased without their inclusion in the Kazakhstan National Medicinal Formulary, such as atropine sulfate, sodium bicarbonate, sodium chloride (crystalline salt), nitroxoline, and nitrofural. The pharmacoeconomics analysis of antibiotics usage for 2018-2021 showed a sharp increase in the%age of costs. Conclusion: The study showed an increase in funding for pharmacotherapy in the department of nephrology, which increases the availability of medicines. However, the trend in prescribing drugs with poor evidence base level, and the increase in the proportion of antibiotic prescription, require immediate intervention including the utilization of clinical pharmacy services for regular assessment of the pharmacoeconomic feasibility of antibiotic therapy. This will improve the quality of medical care and reduce the financial costs.

31 October 2021 in Наука и здравоохранение
Verified
Journal Article
Open access
КДКалиева Д.е.
Калиева Д.е.
ATAssiya Turgambayeva
Assiya Turgambayeva
КЗКеримбаева З.а.
Керимбаева З.а.
ЖСЖумамбаева С.м.
Жумамбаева С.м.
Актуальность: В современном мире расходы на лекарственные препараты являются очень высокими. Одна из мер по сокращению трат здравоохранения - применение генериков. Замена оригинального /референтного/ патентованного лекарственного препарата на воспроизведенный лекарственный препарат практикуется в большинстве стран и позволяет высокоэффективно расходовать бюджетные средства, а также улучшает доступ к лекарственным препаратам среди различных слоев населения. Однако низкая осведомленность и нежелание медицинских работников назначать генерики может негативно влиять на рациональное использование непатентованных лекарственных препаратов. Цель: Анализ литературных данных, посвященных изучению осведомленности о генерических препаратах среди медицинского персонала и пациентов. Стратегия поиска: Проведен поиск научных публикаций в поисковых системах PubMed, CochraneLibrary, GoogleScholar, в электронной научной библиотеке eLibrary.ru, CyberLeninka. Критерии включения: публикации Казахстанских авторов, а также работы ученых ближнего и дальнего зарубежья; глубина поиска составила 10 лет (2010-2020). Исследование было осуществлено путем поиска ключевых слов: генерики, осведомленность, анкета, замена рецепта. В обзор включены результаты поперечных исследований и систематических обзоров. Проанализировано более 1200 публикаций, в анализ включено 59 работ. Результаты: осведомленность о генерических препаратах среди медицинского персонала и пациентов остается не удовлетворительной. Это обусловлено множеством факторов, среди которых главными являются низкий уровень знаний врачей о концепции биоэквивалентности, а также сомнения в эффективности, безопасности и переносимости воспроизведенных лекарственных препаратов. Выводы: Должны быть приняты адекватные меры для повышения осведомленности общественности о генерических препаратах. Background. In the modern world, the costs of medicines are very high. One of the measures to reduce the cost of health care - the use of generic drugs. Substitution of the original/reference/patented drug on generic is practiced in most countries and allows you to spend budget funds effectively and improves access to drugs for all patients. However, low awareness and unwillingness of medical workers to prescribe generics can negatively affect the rational use of substitutes for generics. Aim of the study. to analyze published data regarding the awareness of generic drugs among medical staff and patients. Search strategy. Search for scientific publications in the search engines such as PubMed, Cochrane Library, GoogleScholar, in the electronic scientific library eLibrary.ru, CyberLeninka. Inclusion criteria: publications of Kazakhstan authors, as well as scientific works from the near and far abroad; the search depth was 10 years (2010-2020). The study was carried out by next keywords search: generic drugs, awareness, questionnaire, prescription substitution. The review included the results of cross-sectional studies and systematic reviews. More than 1200 publications were analyzed, 59 works were included in the analysis. Results. awareness of generic drugs among medical staff and patients remains unsatisfactory. This is due to many factors, among which the main ones are the low level of knowledge of doctors about the concept of bioequivalence, as well as doubts about the efficacy, safety and tolerability of the drug. Conclusions. Adequate measures should be taken to increase public awareness of generic drugs. Өзектілігі: Қазіргі әлемдедәрі- дәрмектернің бағасы өте жоғары. Денсаулық сақтау шығындарын төмендетуге бағытталған шаралардың бірі - генериктерді қолдану. Түпнұсқалық/анықтамалық/патенттелген дәрілік препаратты қайта өндірілген дәрілік препаратпен ауыстыру көптеген елдерде тәжірибеге енеді және бюджетті тиімді жұмсауға мүмкіндік береді, сонымен қатар халықтың әр түрлі топтарының дәрі-дәрмектерге қол жетімділікті жақсартады. Алайда медициналық қызметкерлердің хабардар еместігі және генериктерді тағайындауға құлықсыздығы...

31 December 2022 in Наука и здравоохранение
Verified
Journal Article
Open access
ТБТурмаханбетов Б.м.
Турмаханбетов Б.м.
КЗКеримбаева З.а.
Керимбаева З.а.
СУСамарова У.с.
Самарова У.с.
RDReeti D.
Reeti D.
ТГТокмурзиева Г.ж.
Токмурзиева Г.ж.
Актуальность исследования. Злокачественные новообразования являются второй по значимости причиной смерти человечества в мире. По оценкам ООН, ежегодно во всем мире регистрируется около 19,3 млн. новых случаев рака, при этом по верхним дыхательным путям свыше 286 тыс. новых случаев с явным преобладанием участков полости рта и глотки, что приводит к ежегодной заболеваемости 7,3 на 100 000 человек. Цель исследования. Изучение распространенности рака верхних дыхательных путей и причины возникновения в южных регионах Республики Казахстан. Материалы и методы. Нами проведено ретроспективное, описательное и аналитическое исследование за период 2016-2020 гг. В исследовании были охвачены пациенты, поступившие в онкологические центры по поводу злокачественного новообразования верхних дыхательных путей по коду С30, С31, С32 согласно МКБ-10. Также использованы данные информационных систем: портал «Бюро госпитализации», электронный регистр стационарных больных, системы управления качеством медицинских услуг, комплексная медицинская информационная система «DamuMed». Результат исследования. В ходе исследования изучено 213 случаев рака верхних дыхательных путей, что составляет 32,5 случая в год в южном регионе Казахстана. Средний возраст пациентов составил 52,3 ± 4 года. Наибольшее количество выявлено в возрастной группе 61-70 лет (42,7%). Вместе с тем, наблюдается явное преобладание мужчин (83,1%) при соотношении полов 4,9. Семейный анамнез рака зарегистрирован у 6,5% пациентов. В 42,7% случаев среди факторов риска преобладали алкогольная и табачная зависимости. Однако, в 25,4% случаях не выявлены факторы, способствующие возникновению рака. Заключение. По полученным данным было установлено, что рак верхних дыхательных путей относительно часто встречается в повседневной практике, в основном у взрослых мужчин с алкогольной и табачной зависимостями в анамнезе. Результаты исследования позволили найти факторы, способствующие возникновению злокачественного новообразования, которые необходимы для обновления базы местных и республиканских эпидемиологических данных. Background. Malignant neoplasms are the second leading cause of death in the world. According to UN estimates, about 19.3 million new cases of cancer are registered worldwide every year, over 286 thousand new cases in the upper respiratory tract with a clear predominance of oral and pharyngeal areas, which leads to an annual incidence of 7.3 per 100,000 inhabitants. The aim. To study the prevalence of upper respiratory tract cancer and its causes in the southern regions of the Republic of Kazakhstan. Materials and methods. We conducted a retrospective, descriptive and analytical study for a five-year period (2016-2020). The study covered patients admitted to cancer centers for malignant neoplasm of the upper respiratory tract according to the code C30, C31, C32 according to ICD-10. The data of information systems were used: the portal "Bureau of Hospitalization", the electronic register of inpatient patients, quality management systems of medical services, the complex medical information system «DamuMed». Results. During the period of our study, 213 cases of upper respiratory tract cancer were collected, which is 32.5 cases per year. The average age of patients was 52.3 ± 4 years. It is most common in the age group of 61-70 years (42.7%). There was a clear predominance of men (83.1%) with a sex ratio of 4.9. A family history of cancer was recorded in 6.5% of patients. Alcohol and tobacco addiction prevailed among the risk factors in 42.7% of cases. However, in 25.4% of cases, no factors contributing to the occurrence of cancer were found. Conclusion. The results obtained by us have established that upper respiratory tract cancer is relatively common in everyday practice, mainly common in adult men with a history of alcohol and tobacco addiction. The results of the study allowed us to find the factors contributing to the appearance of a malignant neoplasm, as well as to update our local and republican epidemiological data. Зерттеудің өзектілігі. Қатерлі ісіктер әлемдегі халық өлімінің екінші себебі болып табылады. БҰҰ бағалауы бойынша, жыл сайын бүкіл әлемде 19,3...

25 February 2022 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
DKDinara Kaliyeva
Dinara Kaliyeva
ATAssiya Turgambayeva
Assiya Turgambayeva
ZKZakira Kerimbayeva
Zakira Kerimbayeva
Before the medicines enter the pharmaceutical market of the Republic of Kazakhstan, the applicant must pass the registration procedure. The process of registration of medicines is necessary to provide the population of Kazakhstan with high-quality, effective and safe medicines, which, in turn, will lead to an improvement in the general health of the population. The study of the registration process of generic medicines is an urgent problem for practical healthcare, which causes scientific and practical interest in this issue and serves as the basis for this study. The search for health policy literature was carried out on the official websites: www.who.int, www.ndda.kz, www.ema.europa.eu and the search for scientific publications was carried out in the search engines: PubMed, GoogleAcademia, eLibrary.ru, Cyberleninka. Further scientific developments in this direction will be of particular relevance and will allow not only to give a comparative description of the registration process of generic medicines, but also to develop recommendations for its improvement.